Modified tumor-infiltrating lymphocytes (TIL)-based interventions have emerged as a viable and potent option to selectively eradicate the tumor population, with minimal side effects.   Till date, several clinical trials have demonstrated the efficacy and therapeutic superiority (over conventional treatment options) of TIL therapies . Their tumor-cell killing efficiency is attributed to the fact that they are pre-sensitized to cancer specific antigens. Additionally, this emerging class of...

Modified tumor-infiltrating lymphocytes (TIL)-based interventions have emerged as a viable and potent option to selectively eradicate the tumor population, with minimal side effects.   Till date, several clinical trials have demonstrated the efficacy and therapeutic superiority (over conventional treatment options) of TIL therapies . Their tumor-cell killing efficiency is attributed to the fact that they are pre-sensitized to cancer specific antigens. Additionally, this emerging class of...

    The growing cases of prostate cancer in the healthcare industry is propelling the market growth.   The global hormone refractory prostate cancer (HRPCA) market is forecast to reach USD 15.64 Billion by 2026, according to a new report by Reports and Data. Hormone refractory prostate cancer (HRPCA), also known as Castrate-Resistant Prostate Cancer (CRPC), is a particular type of cancer that recurs even after hormonal therapy. It has been categorized under...

    Insufficient healthcare infrastructure and low levels of disease diagnosis and treatments, rising prevalence of hemoglobin disorders such as Sickle Cell Disease, thalassemia, Hb C, and Hb E are expected to be high impact growth drivers for the market. According to the current analysis of Reports and Data, the global Hemoglobinopathies market was valued at USD 5.84 Billionin 2019 and is expected to reach USD 15.05 Billion by year 2027, at a CAGR of 10.2% from...

    The global hemostat market is a fast-growing sector and is widely driven by the increasing number of surgeries acquainted with chronic disorders and the rise in the number of sports accidents among athletes and gymnasts. According to the current analysis of Reports and Data, the hemostats market was valued at USD 2,409.4 Million in 2020 and is expected to reach USD 3,862.9 Million by the year 2028, at a CAGR of 6.2%. It is a surgical instrument that is used to control...

    The rising incidence rate of chronic diseases and the increasing number of geriatric population have resulted in boosting the Infusion Therapy market.  The Global Infusion therapy market is forecast to reach USD 10.98 Billion by 2027, according to a new report by Reports and Data. Infusion therapy is used to give antibiotics, and life-saving hydration fluids that are administered with the help of IV to care users. In this therapy, the medication is administered...

    Rising awareness pertaining to hospital-acquired infections and growing incidences of communicable diseases and is propelling market growth. The global Hospital Equipment and Supplies market size is estimated to reach USD 95.00 billion to 2028 from USD 39.54 billion in 2020, delivering a CAGR of 12.3%. The market growth is driven by a huge demand for disposable supplies from hospitals all across the globe to avoid HAIs (hospital-acquired infections) and limit their...

    High investments in R&D of medical displays along with high demand for the multimodality system medical displays from medical settings are propelling the market growth. The global Medical Display Market size is estimated to reach USD 3.06 billion from USD 1.84 billion in 2019, delivering a CAGR of 5.7% through 2027. The increasing penetration of medical imaging systems in the diagnostic care units across the world is driving the market growth. The medical display...

    The rapid proliferation of emerging technologies like Artificial Intelligence and Machine Learning to achieve greater efficiency in healthcare services is expected to drive the market demand. The Global IoT in Healthcare Market size is forecast to grow from USD 60.83 Billion in 2019 to USD 260.75 Billion by 2027, delivering at a CAGR of 19.8% through 2027. The market growth is driven by increasing focus on active patient engagement and patient-centric care, growth of...

Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade   Roots Analysis has announced the addition of “Exosome Therapeutics Market, 2022-2040” report to its list of offerings.   With the advancements in technologies developing targeted drug delivery therapies, the researchers are shifting...

    Increasing demand due to COVID-19 pandemic, technological advancements in the field of PPE market, favorable regulatory scenario, and growing importance of safety and security in healthcare are key factors contributing to high CAGR in the forecast period. According to Reports and Data, the global healthcare personal protective equipment (PPE) market was valued at USD 5,018.3 million in 2019 and is expected to reach USD 8,024.4 million by the year 2027, at a CAGR of...

    The elevating incidence rate of infectious diseases across the globe, the growing number of researches on infectious disease diagnosis and the elevating emphasis on Point-of-care testing, are boosting the Infectious Disease Diagnostics market.  The Global Infectious Disease Diagnostics market is forecast to reach USD 28.03 Billion by 2027, according to a new report by Reports and Data. Immediate diagnosis of infectious disease is the present need of the time due...